utomilumab

has antineoplastic activity; targets 4-IBB receptor

Also Known As:

PF-05082566; PF-5082566; immunoglobulin g2, anti-(human receptor 4-1bb) (human monoclonal pf-05082566 heavy chain), disulfide with human monoclonal pf-05082566 light chain, dimer

Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Blood Proteins: 12679
    - Serum Globulins: 555
      - Immunoglobulins: 30911
        Antibodies: 135587
        Monoclonal Antibodies: 57170
        Humanized Monoclonal Antibodies: 220
        utomilumab: 15
        Immunoglobulin Isotypes: 1094
        Immunoglobulin G: 59781
        utomilumab: 15
    - Immunoproteins: 43
      - Immunoglobulins: 30911
        Antibodies: 135587
        Monoclonal Antibodies: 57170
        Humanized Monoclonal Antibodies: 220
        utomilumab: 15
        Immunoglobulin Isotypes: 1094
        Immunoglobulin G: 59781
        utomilumab: 15
  - Globulins: 3119
    - Serum Globulins: 555
      - Immunoglobulins: 30911
        Antibodies: 135587
        Monoclonal Antibodies: 57170
        Humanized Monoclonal Antibodies: 220
        utomilumab: 15
        Immunoglobulin Isotypes: 1094
        Immunoglobulin G: 59781
        utomilumab: 15

Aron D Thall Selected Research

Aron D Thall Research Topics

Disease

Drug/Important Bio-Agent (IBA)